Trial Site Detail

 

Drug:
NeoBOMB1
Trial:
MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Medizinische Universitat Innsbruk - Universitatklinil fur Nuklearmedizin

     
Innsbruck , 6020
Austria

 

Principal Investigator:
 Irene Virgolini
Contact:
 +43 (0)512/504-22651 irene.virgolini@i-med.ac.at
Activation Status of this Site:
 Active
Notes about this Site:
Medizinische Universitat Innsbruk - Universitatklinil fur Nuklearmedizin Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.